Dr. David Jaffe, MD
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $463.12 | 8 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Neurelis, Inc. | $142.46 | 2 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $139.10 | 2 | $0 (2024) |
| SANOFI PASTEUR INC. | $101.58 | 1 | $0 (2022) |
| BioMarin Pharmaceutical Inc. | $59.81 | 2 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $20.17 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $293.52 | 4 | ACADIA Pharmaceuticals Inc ($139.10) |
| 2022 | $128.62 | 2 | SANOFI PASTEUR INC. ($101.58) |
| 2020 | $20.81 | 1 | Neurelis, Inc. ($20.81) |
| 2018 | $20.17 | 1 | Sunovion Pharmaceuticals Inc. ($20.17) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/16/2024 | BioMarin Pharmaceutical Inc. | Brineura (Drug) | Food and Beverage | In-kind items and services | $32.77 | General |
| Category: CLN 2 | ||||||
| 03/07/2024 | ACADIA Pharmaceuticals Inc | DAYBUE (Drug) | Food and Beverage | In-kind items and services | $117.76 | General |
| Category: RETT SYNDROME | ||||||
| 03/05/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $121.65 | General |
| Category: EPILEPSY | ||||||
| 01/25/2024 | ACADIA Pharmaceuticals Inc | DAYBUE (Drug) | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: RETT SYNDROME | ||||||
| 11/03/2022 | BioMarin Pharmaceutical Inc. | Brineura (Biological) | Food and Beverage | In-kind items and services | $27.04 | General |
| Category: CLN 2 | ||||||
| 09/06/2022 | SANOFI PASTEUR INC. | — | Food and Beverage | In-kind items and services | $101.58 | General |
| 10/14/2020 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: EPILEPSY | ||||||
| 09/12/2018 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: CNS | ||||||
About Dr. David Jaffe, MD
Dr. David Jaffe, MD is a Neurology with Special Qualifications in Child Neurology healthcare provider based in Chesterfield, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1962473033.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Jaffe, MD has received a total of $463.12 in payments from pharmaceutical and medical device companies, with $293.52 received in 2024. These payments were reported across 8 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($463.12).
Practice Information
- Specialty Neurology with Special Qualifications in Child Neurology
- Other Specialties Neurology with Special Qualifications in Child Neurology
- Location Chesterfield, VA
- Active Since 01/27/2006
- Last Updated 05/22/2023
- Taxonomy Code 2084N0402X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1962473033
Products in Payments
- VALTOCO (Drug) $142.46
- DAYBUE (Drug) $139.10
- Brineura (Drug) $32.77
- Brineura (Biological) $27.04
- APTIOM (Drug) $20.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.